Grant

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

CountryUnited States
DeadlineNot published
Published2023-11-24
SectorsIT, software & digital, Health & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity FOR-FD-24-003. CFDA: 93.103

The buyer, the value, the full description and the link to the official notice are available with a free account.